• N&PD Moderators: Skorpio | thegreenhand

Clitoria ternatea - ingredients and uses.

2014 - Evaluation of antinociceptive effect of methanolic leaf and root extracts of Clitoria ternatea Linn. in rats

ABSTRACT
Aim: Clitoria ternatea Linn. (C. ternatea) is an Ayurvedic herb traditionally used as
medicine to relieve infl ammatory, rheumatism, ear diseases, fever, arthritis, eye ailments,
sore throat and body ache. This study aims to evaluate and elucidate the possible
mechanism underlying the antinociceptive action of methanolic extracts of C. ternatea
leaf and root using several antinociception models.
Materials and Methods: The different antinociception models such as hot plate, tail-fl ick
and formalin tests were used along with naloxone (a non-selective opioid antagonist)
to establish the antinociceptive activity of both leaf and root extracts.
Results: Both C. ternatea leaf and root extracts markedly demonstrated antinociceptive
action in experimental animals. Results of formalin test showed that the antinociceptive
activity of the extracts may be mediated at both central and peripheral level. Moreover,
the results of hot plate and tail-fl ick tests further implies that C. ternatea root extract
mediates antinociceptive activity centrally at supraspinal and spinal levels whereas, the
C. ternatea leaf extract’s antinociceptive activity is mediated centrally at supraspinal level
only. It is believed that the opioid receptors are probably involved in antinociceptive
activity of both C. ternatea root extract.
Conclusions: Our studies support the traditional use of C. ternatea leaf and root against
pain. The extracts can also be utilised as a new source of central analgesics in treatment
of pain.
 
2000 - INFLUENCE OF CLITORIA TERNATEA EXTRACTS ON MEMORY AND CENTRAL CHOLINERGIC ACTIVITY IN RATS

ABSTRACT
Clitoria ternatea, commonly known as Shankpushpi, is
widely used in the traditional Indian system of medicine
as a brain tonic and is believed to promote memory
and intelligence. We examined the effectiveness of
alcoholic extracts of aerial and root parts of C. ternatea
at 300 and 500 mg/kg doses orally in rats in
attenuating electroshock-induced amnesia. Extracts at
300 mg/kg dose produced significant memory retention,
and the root parts were found to be more effective.
In order to delineate the possible mechanism
through which C. ternatea elicits the anti-amnesic
effects, we studied its influence on central cholinergic
activity by estimating the acetylcholine content of the
whole brain and acetylcholinesterase activity at different
regions of the rat brain, viz., cerebral cortex,
midbrain, medulla oblongata and cerebellum. Our
results suggest that C. ternatea extracts increase rat
brain acetylcholine content and acetyl cholinesterase
activity in a similar fashion to the standard cerebro
protective drug Pyritinol.
 
2018 - Anti-allergy and anti-tussive activity of Clitoria ternatea L. in experimental animals

Abstract
Ethnopharmacological relevance
Clitoria ternatea flower is traditionally used in the treatment of respiratory disorders
including bronchitis and is one of the ingredients in different Ayurvedic preparations that are
used in respiratory disorders. However, till date there is no scientific report on the antiasthmatic
activity of this flower.
Aim of the study
Ethanolic extract of Clitoria ternatea flowers (ECT) was evaluated for its anti-allergy and
anti-tussive potential in experimental animals. Additionally, the anti-inflammatory potential
of ECT was carried out to draw a plausible mechanism of action of the drug.
Materials and Methods
In-vitro anti-asthmatic activity of ECT was evaluated in goat tracheal chain and isolated
guinea pig ileum preparations. Acute and chronic anti-asthmatic activity of ECT (100, 200
and 400 mg/kg; p.o.) was estimated in histamine aerosol exposed guinea pigs and in OVA
sensitized and challenged mice respectively. Anti-tussive activity of ECT (100, 200 and 400
mg/kg; p.o.) was evaluated against sulfur dioxide- and citric acid-induced cough in
experimental animals. Moreover, the anti-inflammatory activity of ECT (100, 200 and 400
mg/kg; p.o.) was evaluated against carrageenan- and acetic acid-induced inflammation in rats.
Results
: ECT attenuated histamine-induced contraction in both goat tracheal chain and isolated
guinea pig ileum preparations. ECT (400 mg/kg) attenuated histamine-induced dyspnoea and
OVA-induced changes in differential cell count in broncheoalveolar fluid, levels of
interleukins (IL-1beta and IL-6) and immunoglobulin (OVA-sensitive IgG1) in animals. ECT
(400 mg/kg) further ameliorated sulfur dioxide- and citric acid-induced cough in
experimental animals. Additionally, ECT (400 mg/kg) attenuated inflammation in
carrageenan and acetic acid challenged rodents.
Conclusions
Standardized ECT could be considered as a potential therapeutic alternative in the
management of allergy-induced asthma.
 
2020 - The nootropic and anticholinesterase activities of Clitoria ternatea Linn. root extract

Abstract
Background: Clitoria ternatea (CT) is an herbal plant that has been used as a memory
booster in folk medicine. CT root extract has been proven to restore chronic cerebral
hypoperfusion (CCH)-induced memory deficits in a rat model, but the underlying
mechanisms and the toxicity profile following repeated exposure have yet to be explored.
The aim of the study: To investigate the effects of the chronic (28 days) oral administration
of CT root extract on CCH-induced cognitive impairment, neuronal damage and cholinergic
deficit, and its toxicity profile in the CCH rat model.
Materials and methods: The permanent bilateral occlusion of common carotid arteries
(PBOCCA) surgery method was employed to develop a CCH model in male Sprague Dawley
(SD) rats. Then, these rats were given oral administration of CT root extract at doses of 100,
200, and 300 mg/kg, respectively for 28 days and subjected to behavioural tests. At the end of
the experiment, the brain was harvested for histological analysis and cholinesterase activities.
Then, blood samples were collected and organs such as liver, kidney, lung, heart, and spleen
were procured for toxicity assessment.
Results: Chronic treatment of CT root extract at doses of 200 and 300 mg/kg, restored
memory impairments induced by CCH. CT root extract was also found to diminish CCHinduced
neuronal damage in the CA1 region of the hippocampus. High dose (300 mg/kg) of
the CT root extract was significantly inhibited the increased acetylcholinesterase (AChE)
activity in the frontal cortex and hippocampus of the PBOCCA rats. In toxicity study,
repeated doses of CT root extract were found to be safe in PBOCCA rats after 28 days of
treatment.
Conclusions: Our findings provided scientific evidence supporting the therapeutic potential
of CT root extract in the treatment of vascular dementia (VaD)-related cholinergic
abnormalities and subsequent cognitive decline.
 
Last edited:
2011 - Antihistaminic activity of Clitoria ternatea L. roots

ABSTRACT: Clonidine, a a2 adrenoreceptor agonist induces dose dependent catalepsy
in mice, which was inhibited by histamine H1 receptor antagonists but not by
H2 receptor antagonist. Clonidine releases histamine from mast cells which is responsible
for different asthmatic conditions. Clitoria ternatea L. (Family: Fabaceae) is a perimial
twing herb. The roots have anti-inflammatory properties and are useful in severe
bronchitis, asthma. In present study ethanol extract of Clitoria ternatea root (ECTR) at
doses 100, 125 and 150 mg/kg i.p were evaluated for antihistaminic activity using
clonidine and haloperidol induced catalepsy in mice. Finding of investigation showed
that chlorpheniramine maleate (CPM) and ECTR inhibit clonidine induced catalepsy
significantly P < 0.001 when compare to control group, while CPM and ECTR fail to
inhibit haloperidol induced catalepsy. Present study concludes that ECTR possesses
antihistaminic activity.
 
2003 - Clitoria ternatea and the CNS

4. Discussion
In the Ayurvedic system of medicine, the roots, seeds and
leaves of C. ternatea have long been in clinical use. In many
Ayurvedic formulations, the C. ternatea is used as a
substitute for Evolvulus alsinoids (Anonymous, 1995).
Recently, Taranalli and Cheeramkuczhi (2000) reported
memory-enhancing activity of C. ternatea. The results of
the present investigation suggest that C. ternatea possess a
wide spectrum of CNS activity. The CT, though weak,
exhibited nootropic, anxiolytic, antistress, antidepressant
and anticonvulsant activities. The extract reduced lithiuminduced
head twitches, showed tendency (though statistically
insignificant) to inhibit clonidine-induced hypothermia
and reduce sodium nitrite-induced respiratory arrest.
The effect on haloperidol-induced catalepsy was not significant.
The nootropic drugs facilitate intellectual performance,
learning and memory (Giurgea, 1973). However, the neurological
basis of such action is not known. Although
involvement of cholinergic system is well established, the
role of other neurotransmitters cannot be ignored (Hollander
et al., 1986). We have reported decrease in brain contents of
g-aminobutyric acid (GABA) and DA after piracetam
(Chintawar et al., 2002). It has been reported earlier that
increase in the serotonergic transmission can interfere with
learning acquisition and memory consolidation (Ogren,
1982). The role of DA is, however, controversial. Davis
(1989) has shown that learning and memory can proceed
normally despite depletion of brain DA. Piracetam, an
established nootropic drug, is known to augment dopaminergic
activity (Nyback et al., 1979). However, in another
study, Bhattacharya et al. (1989) could not notice any
significant effect of piracetam on DA levels. Brain DA
level was found to decrease after administration of oil of
Celastrus paniculatus, which possesses nootropic activity
(Nalini et al., 1995). The increase in the IR and discrimination
index by CT per se has proved that the plant possesses
nootropic activity. The CT met a major criterion for nootropic
activity, namely, improvement of memory in absence
of cognitive deficit (Poschel, 1988). The decrease in TL by
CT in the EPM is in accordance with the hypothesis of Itoh
et al. (1990) that nootropic drugs decrease TL. The EPM test
is useful in screening effect on long-term memory, whereas
the object recognition test is useful to study the short-term
memory. The improvement in IR by CT on the ninth day
indicated its weak effect on long-term memory.
CT exhibited a weak anxiolytic activity in both animal
models of anxiety, the EPM and light/dark exploration test.
Increase in occupancy of the animals in the open arm or
decrease in the time spent in the enclosed arm indicates the
anxiolytic activity of drug (Pellow et al., 1985). Many
researchers have shown an inverted U-shaped dose–
response curve with anxiolytics (Weiss et al., 1981; Insel
et al., 1984; Nutt and Glue, 1991), but this was not observed
with CT. CT dose-dependently increased the time spent in
the open arm. The light/dark exploration test measures
natural aversion of mice and rats to brightly lit places.
Several researchers have used this model for evaluation of
anxiolytic agents (Imaizumi et al., 1996; Sanchez, 1995;
Bilkiei-Gorz et al., 1998). The observation that CT
increased time spent in the lit box is in congruence with
these studies.
An imbalance between excitatory and inhibitory neurotransmitters
is responsible for seizures. Many drugs that
increased the brain content of GABA have exhibited anticonvulsant
activity against seizures induced by MES and
PTZ. The MES is probably the best validated method for
assessment of antiepileptic drugs in the generalized tonicclonic
seizures (Fisher, 1989; Loscher et al., 1991). The
PTZ-induced seizures are similar to the symptoms observed
in the absence seizures, and the drugs useful in the treatment
of absence seizures suppress PTZ-induced seizures (McNamara,
1996). CT significantly delayed the onset of convulsions
in PTZ-induced convulsions and also delayed the
duration of tonic hindlimb extension in MES-induced convulsions.
These observations suggest possibility of usefulness
of CT in treatment of seizures.
Existence of cognitive problem in depressive illness is
well known (Allain et al., 1990). Amitriptyline and imipramine
have anticholinergic effects and this may attribute to
the most adverse effects on memory. Because of increasing
incidence of Alzheimer’s disease and depression, there is a
need for developing an antidepressant that could be useful in
Alzheimer’s disease and depression. A disturbed receptor
balance could be contributing to the symptomatology of
depression and cognitive impairment (Berendsen, 1995;
Meneses and Hong, 1997). Fluoxetine, a selective serotonin
reuptake inhibitor, reduces total duration of immobility.
Both clinical and animal studies have strongly implicated
a critical role of 5-HT1A, 5-HT1B and 5-HT2A receptors in
antidepressant response (Barnes and Sharp, 1999). Total
duration of immobility was decreased by CT. In addition,
CT did not produce sedation and behavioral toxicity but
rather improved cognitive abilities.
Stress is known to alter the physiological homeostasis of
the organism. Stress elicits various endocrinal and visceral
changes including gastric mucosal integrity (Ander, 1984).
Stress increases brain serotonin level (Bhattacharya and
Bhattacharya, 1982) and leaves a lasting imprint on cognitive
behavior (Jaiswal and Bhattacharya, 1993). Ray et al.
(1991) have shown that peripheral and central injections of
diazepam attenuate several stress responses like gastric
ulcerogenesis. CT decreased ulcer index dose-dependently
and showed antistress activity.
The increase in serotonergic transmission can interfere
with learning acquisition and memory consolidation (Ichihara
et al., 1993; Arnsten et al., 1997; Barnes et al., 1990).
Lithium-induced head twitches are due to increased formation
of serotonin in the CNS (Wielosz and Kleinrok, 1979).
Both piracetam and CT reduced the head twitches significantly,
and CT at the same dose exhibited increased IR in
EPM, suggesting a link between cognitive improvement and
decreased serotonergic transmission by CT.
It is well known that amphetamine, which markedly
augments central noradrenergic activity, leads to mental
confusion and retards memory consolidation. The amnesic
effect of electroconvulsive shock, which is attenuated by
piracetam, is known to produce marked increase in the
turnover of rat brain NA (Bhattacharya et al., 1989).
Clonidine, a presynaptic a-adrenoceptor agonist, induces
hypothermia by reducing noradrenergic release (Drew et al.,
1977). Piracetam and CT failed to reverse clonidine-induced
hypothermia, indicating that noradrenergic mechanism was
not involved in the central effects of CT.
Sodium nitrite is known to convert hemoglobin into
methemoglobin, thereby reducing oxygen-carrying capacity
and cholinergic transmission and ultimately leading to
death (Hock, 1993). Piracetam and CT failed to decrease
the effect of sodium nitrite. This indicated that CT did not
increase the cholinergic transmission in the CNS. Anticholinergics
are useful as initial drugs in Parkinson’s disease,
but they deteriorate cognitive behavior in Alzheimer’s
disease. This is the most important observation of the
present study because the modern medicine does not have
any drug that would be useful in treatment of Alzheimer’s
disease and Parkinson’s disease simultaneously. This
strongly suggests that there can be a category of drugs
useful in Alzheimer’s disease and Parkinson’s disease.
Thus, plants can provide a drug that would be useful in
these diseases.
The striatum, the ventrorostral region and the nucleus
accumbens septi have been implicated as the major brain
structures involved in the antipsychotic-induced catalepsy
(Duvoisin, 1967). Antipsychotic-induced catalepsy appears
to be due to blockade of DA neurotransmission (Janssen,
1965; Carlesson, 1990; Seeman, 1980). In the present study,
CT did not significantly increase haloperidol-induced catalepsy.
Brain DA level was found to decrease after administration
of oil of C. paniculatus (Nalini et al., 1995). This
suggests that CT does not significantly alter DA levels in the
substantia nigra. Thus, in conclusion, the extract was found
to possess nootropic, anxiolytic, antistress and anticonvulsant
activities. The present study is based on behavioral
effects, and specific binding studies and measurement of
neurotransmitter levels in freely moving animals are necessary
to understand the mode of action and suitability of the
extract for human use.
 
2003 - Anti-inflammatory, analgesic and antipyretic properties of Clitoria ternatea root

Abstract
Clitoria ternatea roots methanol extract when given by oral route to rats was found to
inhibit both the rat paw oedema caused by carrageenin and vascular permeability induced by
acetic acid in rats.Mor eover, the extract exhibited a significant inhibition in yeast-induced
pyrexia in rats.In the acetic acid-induced writhing response, the extract markedly reduced
the number of writhings at doses of 200 and 400 mgykg (p.o.) in mice.
 
2019 - Nootropic and Anti-Alzheimer's Actions of Medicinal Plants Molecular Insight into Therapeutic Potential to Alleviate Alzheimer's Neuropathology

active metabolites:
Table 4 Neuroprotective, memory-enhancing, and antioxidant activities of the active metabolites of Clitoria ternatea Bioactive metabolites In vitro studies Ex vivo studies In vivo studies (animal studies)

Taraxerol Antioxidant activity [83] Improve memory impairments in AD [84]
p-Hydroxycinnamic acid Antioxidant activity [85] Neuroprotective effects [86]
ß-sitosterol Antioxidant activity [87] Improve memory deficits [88]
Kaempferol Antioxidant activity [89] Augment cellular antioxidant defense [59]
Anthocyanins Antioxidant activity [90] Antioxidant activity [91]
Taraxerone Antioxidant activity [92]
Delphinidin Antioxidant activity [93]

Clitoria ternatea
Learning, Memory-Enhancing, and Anti-Alzheimer’s Effects
In a study by Rai et al. [71] assessed the effects of Clitoria
ternatea (C. ternatea) aqueous root extract on memory and
learning in neonatal rat pups (7 days old) by using PAT, EPM,
and T-maze test or spatial learning tests. Interestingly, it was
found in this study that memory in rats increased considerably
when an extract of C. ternatea roots was used at different doses
as an oral treatment. Conversely, neonatal rat pups were
intubated at the dose of 50 mg/kg and 100 mg/kg of aqueous
root extract of C. ternatea for 30 days during their growth spurt
period. Memory improving properties was observed with
C. ternatea root extract; nonetheless, it did not disturb motor
activity. In addition, in the case of both time points of behavioral
tests, it showed enhanced retention and spatial learning
performance. Henceforth it was evident that permanent change
in the brain mediated by C. ternatea extracts resulted in enhanced
learning and memory. This memory increasing activity
was significantly higher in neonatal rats (i.e., especially during
their growth spurt period) treated for 30 days with C. ternatea
extract (100 mg/kg body weight). So, it seems that treatment
with C. ternatea extract can cause permanent changes in the
rat’s brain and can enhance memory and learning [71].
In rats, in case of the alcoholic extracts of aerial parts and
roots of C. ternatea (i.e., 300 and 500 mg/kg) lessened amnesia
induced by electroshock through conditional avoidance response
paradigm [72]. C. ternatea extract, at the dose of 300 mg/kg,
triggered substantial retention of memory and the root parts
found to be significantly effective; however, the dose of
300 mg/kg appeared very high. The researchers in this study also
assessed the most likely mechanism by which C. ternatea exerts
the anti-amnesic effects on central cholinergic activity. For this
assessment, they evaluated the whole brain’s acetylcholine
(ACh) content and AChE activity at different parts of the rat
brain, specifically midbrain, cerebral cortex, cerebellum, and
medulla oblongata. In this study, in comparison with aerial parts,
C. ternatea extract of roots was found to be more effective in
lessening memory deficits. Alternatively, the pathway via which
C. ternatea generated retention of memory seems to be analogous
to pyritinol (i.e., standard cerebro protective drug). In rat
hippocampus, the effects of aqueous C. ternatea root extract on
the ACh content were discovered [73, 74]. In contrast, when
C. ternatea aqueous root extracts were used at a dose of
100 mg/kg for 30 days in neonatal rat pups (i.e., 7 days old)
and young adult rats (i.e., 60 days old), substantial increase in
the content of ACh was noticed in their hippocampi in comparison
with that of age-matched controls. In 90-day old control
rats, hippocampal ACh content was found to be considerably
less as compared to 37-day old control rats. In the central nervous
system, ACh is considered as one of the key neurotransmitters.
ACh helps to enhance attention and also ease the process
of learning. As a result, in rat hippocampus, increased ACh
content possibly the neurochemical basis for enhanced learning
and memory. Treatment with aqueous C. ternatea root extract
might be effective in strengthening disrupted cholinergic transmission
in specific age-related memory disorders. Furthermore,
in normal individuals, learning and enhanced memory may also
be facilitated by aqueous root extract of C. ternatea. However, it
is yet to be discovered whether this extract exerts similar action
in senile animals or not [75].
Rai et al. [76], in another study, showed that retention in the
PAT memory can also be ominously improved by using
C. ternatea. When young adult rats were orally intubated for
30 days at a dose of 100 mg/kg per day, increased retention
was noticed 48 h after the learning process in the same group
of C. ternatea treated young adult rats in comparison with agematched
saline controls. This further specifies an upsurge in the
capacity to maintain avoidance memories, suggesting possible
effects exerted by C. ternatea on amygdaloid neurons. These
findings collectively specify that treatment by aqueous root extract
of C. ternatea has a specific contribution in the increment of
amygdaloid neuronal dendritic arborization and also hippocampal
CA3 neurons [76]. In a different study Rai et al., [77] further
assessed the effect of C. ternatea aqueous root extract on the
dendritic cytoarchitecture of amygdala neurons [77]. Along with
age-matched saline controls, when Wistar rats (i.e., either sex)
were orally intubated with C. ternatea aqueous root extract (i.e.,
50 and 100 mg/kg) for 30 days and exposed to PAT, a significant
increase was found in retention of passive avoidance and learning.
These rats were sacrificed by decapitation after the PAT. The
amygdala was treated for Golgi staining and following staining
neuronswere traced by using a camera lucida and examined. The
findings of the study revealed a substantial increase in branching
points, dendritic processes, and dendritic intersections that arise
from the soma of amygdaloid neurons in aqueous root extract
treated rats when compared to age-matched saline controls.
Besides that, in the aqueous C. ternatea root extract, treated rats
enhanced dendritic arborization of amygdaloid neurons links
with the improved passive avoidance learning and memory.
The results of the study showed that aqueous root extract of
C. ternatea improves memory by triggering the functional
growth of amygdala neurons. Alternatively, an aqueous root extract
of C. ternatea also influences the structures of the brain
which governs learning and memory specifically amygdala and
hippocampus. These changes related to behavior are considered
comparatively permanent and denotes that C. ternatea can affect
neurotransmitter biosynthesis namely ACh, which plays a significant
role in the learning process and also in memory. In addition,
these changes can also cause permanent changes in the brain.
Moreover, C. ternatea perhaps also facilitates long-term potentiation
[71]. The aqueous root extract of C. ternatea was not only
found to support neurogenesis in the amygdala; nevertheless, it
also triggers the release of neuromodulators or hormones that
control the neurotransmitters and neuromodulators activity specifically
which play vital roles in memory and learning, thus
playing roles in improving memory and learning. Following
comprehensive clinical trials in adults, it was detected that treatment
by aqueous root extract of C. ternatea possibly be foreseen
as an enhancer of memory and also might be beneficial in the
treatment of amygdala-related neurodegenerative disorders [77].
Neuroprotective, Cognition-Enhancing, and Anti-Alzheimer’s
Effects
Talpate et al. [78] analyzed the nootropic and neuroprotective
activity of ethanol extract of C. ternatea extract on diabetesassociated
cognitive impairment in a rat model. The ethanol
extract of C. ternatea (200 and 400 mg/kg) caused a substantial
upsurge in spatial reference memory (P< 0.001), spatial
working memory (P < 0.05) and spatial working-reference (P
< 0.001) in retention trials on Morris water maze, Y-maze and
radial armmaze accordingly. Instead, marked decrease in lipid
peroxide (P < 0.001), AChE activity (P< 0.05), total nitric
oxide (P< 0.001) and significant increase in CAT, SOD,
and GSH levels were detected in animals treated with ethanol
extract of C. ternatea (200 and 400 mg/kg) in comparison
with diabetic control group [78].
Recently, in a study, Rajashree et al., [79] in the streptozocininduced
young diabetic rats, examined the effects of the alcoholic
roots extracts of the C. ternatea on the behavioral and
cognitive changes. A substantial improvement was observed
only in the memory and learning among the diabetic group
and C. ternatea groups of rats [79]. In another study by
Ravishankar et al., [80] examined the neuroprotective effect
of ethanolic C. ternatea root extracts against amnesia triggered
by stress. In this study, conditioned avoidance response by
employing Cook’s pole climbing apparatus and transfer latency
using EPM were used in stress-induced and normal rats to
evaluate cognitive-improving activities. When C. ternatea
was orally administered daily at doses of 150 and 300 mg/kg,
it improves cognition in a dose-dependent way in normal rats.
In extract treated stress-induced rats, fast retrieval was observed
as compared to the stress control group [80]. The neuroprotective
anticholinergic, cognitive, and memory-enhancing, as well
as antioxidant, effects of the C. asiatica extracts and its bioactive
metabolites are specified in Table 3 and Table 4.
Neuropharmacological Effects
In rats and mice, C. ternatea root’s ethanol extract was assessed
for various neuropharmacological actions including exploratory
behavior, general behavior, sleeping time induced by phenobarbitone
and muscle relaxant activity. At the doses of 100 and
150 mg/kg, the extract caused a decrease in spontaneous activity,
reduction in the exploratory behavioral pattern by Y-maze and the
head dip test, decrease in the muscle relaxant activity by rotarod,
traction tests, and 300 inclined screens [94]. Furthermore,
C. ternatea extract considerably increased the phenobarbitone-
mediated sleeping time [94]. In rats, Kulkarni et al. [81] observed
the effect exerted by an alcoholic extract of aerial part of
C. ternatea on special discrimination. When alcoholic extract
was given orally at a dose of 460 mg/kg, a significant increase
in the time taken to traverse the maze was noticed, which was
alike to that generated by chlorpromazine; nonetheless, at a lower
dose (i.e., 230 mg/kg), chlorpromazine was not effective.
Nootropic and Anxiolytic Effects
EPM and object recognition tests were used to evaluate the
nootropic activity of C. ternatea aerial parts extract [82]. On
the 9th day, a marked increase in inflection ratio was noticed in
the case of the animals, which were treated with C. ternatea
(100 mg/kg). It was noticed in the object recognition test that
mice which were treated with C. ternatea took considerably
less amount of time to find out the familiar object as compared
to the new object and markedly decreased the discrimination
index. So, the increased discrimination index and inflection
ratio clearly indicate the nootropic activity of the species. In
addition, C. ternatea also met a key condition for nootropic
activity, which is specifically the memory improvement in cognitive
deficit’s absence. In association with the nootropic drug’s
assumption, a decrease in transfer latency was observed by
C. ternatea in the EPMtest.However, improved inflection ratio
on the 9th day denoted C. ternatea’s less significant effect on
long-term memory. Conversely, Jain et al. [82] conducted a
study by employing the light or dark exploration and EPM test
to evaluate the anxiolytic potential of a methanolic extract of
aerial part of C. ternatea. It was observed that when C. ternatea
(100–400 mg/kg) was administered orally, it augmented the
time spent in the light-box and the time spent in the open
arm. In contrast, in the same study, it was noticed that there is
a reduction in time spent in the dark box. Failure to exert any
substantial effect in both animal models of anxiety was noticed
with the oral administration of C. ternatea at a dose of
30 mg/kg; however, a weaker effect was detected in case of
both the animal models.Malik et al. [95] stated that C. ternatea
aqueous methanol extract showed supremememory-improving
and anxiolytic effect at the doses of 100 and 200 mg/kg.
Anti-Alzheimer’s Effects in Human Studies
In a randomized, crossover study, Chusak et al. [96], in 15
healthy men, estimated the effects of C. ternatea flower extract
on antioxidant status and postprandial plasma glycemia
response. Surprisingly, after 30 min of ingestion, the insulin
and postprandial plasma glucose levels were inhibited when
consuming sucrose and 2 g and 1 g C. ternatea flower extract.
Furthermore, insulin concentration in the fasting state and
glucose level in plasma was not altered due to this extract
consumption. Instead, in the individuals who received 2 g
and 1 g C. ternatea flower extract, a decrease in the level of
MDA and a marked rise in plasma antioxidant capacity (i.e.,
oxygen radical absorbance capacity, trolox equivalent antioxidant
capacity, ferric reducing ability of plasma, and protein
thiol) were detected. In addition, sucrose-stimulated reduction
in trolox equivalent antioxidant capacity and oxygen radical
absorbance capacity and also the increase in plasma MDA
were protected due to the C. ternatea flower extract consumption.
These results suggested that, without hypoglycemia in
the fasting state, plasma antioxidant capacity is increased due
to an acute ingestion of C. ternatea flower extract. It has been
summarized, in adults, following detailed clinical trials, that
treatment with aqueous root extract of C. ternatea may be
beneficial in the treatment of neurodegenerative diseases relating
the amygdala and might also be foreseen as an enhancer
of memory [77]. The possible mechanism of action for anti-
Alzheimer’s potential of C. ternatea is illustrated in Fig. 2.
 
2020 - Extraction methods of butterfly pea (Clitoria ternatea) flower and biological activities of its phytochemicals

2020-Extraction-methods-of-butterfly-pea-Clitoria-ternatea-flower-and-biological-activities-of-its-p.jpg


Abstract Clitoria ternatea or commonly known as ‘Butterfly
pea’ has been used traditionally in Ayurvedic medicine
in which various parts of the plants are used to treat
health issues such as indigestion, constipation, arthritis,
skin diseases, liver and intestinal problems. The flowers of
C. ternatea are used worldwide as ornamental flowers and
traditionally used as a food colorant. This paper reviews
the recent advances in the extraction and biological activities
of phytochemicals from C. ternatea flowers. The
application of maceration or ultrasound assisted extraction
greatly increased the yield (16–247% of increase) of phytochemicals
from C. ternatea flowers. Various phytochemicals
such as kaempferol, quercetin and myricetin
glycosides as well as anthocyanins have been isolated from
C. ternatea flowers. Clitoria ternatea flower extracts were
found to possess antimicrobial, antioxidant, anti-inflammatory,
cytotoxic and antidiabetic activities which are
beneficial to human health. Clitoria ternatea flower is a
promising candidate for functional food applications owing
to its wide range of pharmacotherapeutic properties as well
as its safety and effectiveness.
 
2015 - A Strategy to Employ Clitoria ternatea as a Prospective Brain Drug Confronting Monoamine Oxidase (MAO) Against Neurodegenerative Diseases and Depression

2015-A-Strategy-to-Employ-Clitoria-ternatea-as-a-Prospective-Brain-Drug-Confronting-Monoamine-Oxidas.jpg


2015-A-Strategy-to-Employ-Clitoria-ternatea-as-a-Prospective-Brain-Drug-Confronting-Monoamine-Oxidas.jpg


Abstract Ayurveda is a renowned traditional medicine practiced in India from ancient times and Clitoria ternatea is one
such prospective medicinal herb incorporated as an essential constituent in a brain tonic called as medhya rasayan for
treating neurological disorders. This work emphasises the significance of the plant as a brain drug there by upholding
Indian medicine. The phytochemicals from the root extract were extricated using gas chromatography–mass spectrometry
assay and molecular docking against the protein Monoamine oxidase was performed with four potential compounds along
with four reference compounds of the plant. This persuades the prospect of C. ternatea as a remedy for neurodegenerative
diseases and depression. The in silico assay enumerates that a major compound (Z)-9,17-octadecadienal obtained from the
chromatogram with a elevated retention time of 32.99 furnished a minimum binding affinity energy value of -6.5 kcal/mol
against monoamine oxidase (MAO-A). The interactions with the amino acid residues ALA 68, TYR 60 and TYR 69 were
analogous to the reference compound kaempferol-3-monoglucoside with a least score of -13.90/-12.95 kcal/mol against
the isoforms (MAO) A and B. This study fortifies the phytocompounds of C. ternatea as MAO-inhibitors and to acquire a
pharmaceutical approach in rejuvenating Ayurvedic medicine.
 
paper roll:

2000 - INFLUENCE OF CLITORIA TERNATEA EXTRACTS ON MEMORY AND CENTRAL CHOLINERGIC ACTIVITY IN RATS.pdf
2003 - Anti-inflammatory, analgesic and antipyretic properties of Clitoria ternatea root.pdf
2003 - Clitoria ternatea and the CNS.pdf
2011 - Antihistaminic activity of Clitoria ternatea L. roots.pdf
2014 - Evaluation of antinociceptive effect of methanolic leaf and root extracts of Clitoria ternatea Linn. in rats.pdf
2015 - A Strategy to Employ Clitoria ternatea as a Prospective Brain Drug Confronting Monoamine Oxidase (MAO) Against Neurodegenerative Diseases and Depression.pdf
2018 - Anti-allergy and anti-tussive activity of Clitoria ternatea L. in experimental animals.pdf
2019 - Nootropic and Anti-Alzheimer's Actions of Medicinal Plants Molecular Insight into Therapeutic Potential to Alleviate Alzheimer's Neuropathology.pdf
2020 - Extraction methods of butterfly pea (Clitoria ternatea) flower and biological activities of its phytochemicals.pdf
2020 - The nootropic and anticholinesterase activities of Clitoria ternatea Linn. root extract.pdf
 
slightly sedating and calming effect, the extract is kinda anthracite in color. almost no taste. nasal consume is favored with all 100x extracts i got.
 
ok, just tested the remaining 500mg 100x extract or so rectally. even at this big dose a rather subtile effect if any, could be placebo id say.
 
Top